Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets
MedComm · 2024-11 · 5 (11)
DOI: 10.1002/mco2.786 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 15.10.2024. Verfasst von Ayesha Nisar und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Genetic Evolution & Animal Models, KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Ins…. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 307 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Aging is a complex biological process characterized by the gradual decline of cellular functions, increased susceptibility to diseases, and impaired stress responses. Hypoxia, defined as reduced oxygen availability, is a critical factor that influences aging through molecular pathways involving hypoxia‐inducible factors (HIFs), oxidative stress, inflammation, and epigenetic modifications. This review explores the interconnected roles of hypoxia in aging, highlighting how hypoxic conditions exacerbate cellular damage, promote senescence, and contribute to age‐related pathologies, including cardiovascular diseases, neurodegenerative disorders, cancer, metabolic dysfunctions, and pulmonary conditions. By examining the molecular mechanisms linking hypoxia to aging, we identify key pathways that serve as potential therapeutic targets. Emerging interventions such as HIF modulators, antioxidants, senolytics, and lifestyle modifications hold promise in mitigating the adverse effects of hypoxia on aging tissues. However, challenges such as the heterogeneity of aging, lack of reliable biomarkers, and safety concerns regarding hypoxia‐targeted therapies remain. This review emphasizes the need for personalized approaches and advanced technologies to develop effective antiaging interventions. By integrating current knowledge, this review provides a comprehensive framework that underscores the importance of targeting hypoxia‐induced pathways to enhance healthy aging and reduce the burden of age‐related diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Genetic Evolution & Animal Models, KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology Chinese Academy of Sciences Kunming Yunnan China.
- Kunming College of Life Science University of Chinese Academy of Sciences Kunming China.
- Key Laboratory of Healthy Aging Research of Yunnan Province, Kunming Institute of Zoology Chinese Academy of Sciences Kunming Yunnan China.
- Department of Cell Biology, School of Life Sciences Central South University Changsha Hunan China.
- Institute of Molecular Biology and Biotechnology The University of Lahore Lahore Pakistan.
- Department of Endocrinology The Second Affiliated Hospital of Dali University (the Third People's Hospital of Yunnan Province) Kunming Yunnan China.
ORCID-Profile: Yonghan He
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Nisar, A., Khan, S., Li, W., Hu, L., Samarawickrama, P. N., Gold, N. M., Zi, M., Mehmood, S. A., Miao, J., & He, Y. (2024). Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets. MedComm, 5(11). https://doi.org/10.1002/mco2.786
Vancouver
Nisar A, Khan S, Li W, Hu L, Samarawickrama PN, Gold NM, et al. Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets. MedComm. 2024;5(11). doi:10.1002/mco2.786
BibTeX
@article{Nisar2024,
author = {Nisar, Ayesha and Khan, Sawar and Li, Wen and Hu, Li and Samarawickrama, Priyadarshani Nadeeshika and Gold, Naheemat Modupeola and Zi, Meiting and Mehmood, Sardar Azhar and Miao, Jiarong and He, Yonghan},
title = {Hypoxia and aging: molecular mechanisms, diseases, and therapeutic targets},
journal = {MedComm},
year = {2024},
volume = {5},
number = {11},
doi = {10.1002/mco2.786}
}
EUVIMED